---
figid: PMC6462526__zbc0151903700006
figtitle: 5′-IT treatment affects intra-/extracellular adenosine balance and INSM1
  expression leading to NB tumor cell death
organisms:
- NA
pmcid: PMC6462526
filename: zbc0151903700006.jpg
figlink: pmc/articles/PMC6462526/figure/F6/
number: F6
caption: 5′-IT treatment affects intra-/extracellular adenosine balance and INSM1
  expression leading to NB tumor cell death. 5′-IT controls intra-/extracellular adenosine
  that mediates through the inhibition of ADK via the AMP signaling pathway. Intracellular
  adenosine could also direct the inosine pathway through ADA (ADA inhibitor, pentostatin).
  Imbalance of intra-/extracellular adenosine promotes adenosine export through the
  nucleoside transporter (NT, NT inhibitor, dipyridamole). Extracellular adenosine
  triggers the adenosine receptor-3 (ARA3) signaling pathway resulting in the suppression
  of cAMP, which enhances β-catenin phosphorylation toward cytoplasmic proteasomal
  degradation. 5′-IT, pentostatin, U0126, and dipyridamole (green labels) are inhibitors
  for ADK, ADA, MEK1/2-ERK1/2, and NT pathways. 2-Cl-IB-MECA is an ARA3 agonist. 5′-IT
  down-regulates pAKT, pGSK3β, β-catenin, LEF-1, pERK1/2, cyclin D1, INSM1, N-Myc
  and activates caspase-3, and p53 for NB apoptosis.
papertitle: 5′-Iodotubercidin represses insulinoma-associated-1 expression, decreases
  cAMP levels, and suppresses human neuroblastoma cell growth.
reftext: Chiachen Chen, et al. J Biol Chem. 2019 Apr 5;294(14):5456-5465.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9711453
figid_alias: PMC6462526__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6462526__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6462526__zbc0151903700006.html
  '@type': Dataset
  description: 5′-IT treatment affects intra-/extracellular adenosine balance and
    INSM1 expression leading to NB tumor cell death. 5′-IT controls intra-/extracellular
    adenosine that mediates through the inhibition of ADK via the AMP signaling pathway.
    Intracellular adenosine could also direct the inosine pathway through ADA (ADA
    inhibitor, pentostatin). Imbalance of intra-/extracellular adenosine promotes
    adenosine export through the nucleoside transporter (NT, NT inhibitor, dipyridamole).
    Extracellular adenosine triggers the adenosine receptor-3 (ARA3) signaling pathway
    resulting in the suppression of cAMP, which enhances β-catenin phosphorylation
    toward cytoplasmic proteasomal degradation. 5′-IT, pentostatin, U0126, and dipyridamole
    (green labels) are inhibitors for ADK, ADA, MEK1/2-ERK1/2, and NT pathways. 2-Cl-IB-MECA
    is an ARA3 agonist. 5′-IT down-regulates pAKT, pGSK3β, β-catenin, LEF-1, pERK1/2,
    cyclin D1, INSM1, N-Myc and activates caspase-3, and p53 for NB apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADK
  - ADA
  - ADAD1
  - ADAD2
  - ADAR
  - ADARB1
  - ADARB2
  - ADAT1
  - ADAT2
  - ADAT3
  - INSM1
  - GSK3B
  - MYCN
  - CTNNB1
  - LEF1
  - CCND1
  - TP53
  - TP63
  - TP73
  - Adenosine
  - 5-AMP
  - MECA
  - Dipyridamole
  - Inosine
  - U0126
  - Pentostatin
---
